Please check your internet connection and try again.
# Miconazole Vaginal Pessary
## Overview
Miconazole is an imidazole antifungal agent effective against a variety of yeasts and fungi. The vaginal pessary formulation is intended for local treatment of vaginal candidiasis.
## Primary Indications
Treatment of vulvovaginal candidiasis (yeast infection).
## Adult Dosing
* **100 mg pessary:** Insert one pessary vaginally at bedtime for 7 days.
* **200 mg pessary:** Insert one pessary vaginally at bedtime for 3 days.
* **Single-dose 1200 mg pessary:** Insert one pessary vaginally as a single dose.
## Pediatric Dosing
Data for pediatric use of miconazole vaginal pessaries is limited. Prescribing should be based on clinical judgment and available evidence, with caution.
## Dose Adjustments
No dose adjustments are typically required for hepatic or renal impairment due to minimal systemic absorption.
## Contraindications
* Hypersensitivity to miconazole or any component of the formulation.
* Use with oral or topical CYP3A4 substrates (e.g., certain statins, benzodiazepines, calcium channel blockers, opioids). Refer to specific drug interaction references for a comprehensive list.
## Adverse Effects
Common adverse effects include vulvovaginal burning, itching, irritation, and abdominal cramping. Allergic reactions are possible.
## Key Drug Interactions
* **CYP3A4 Inhibitors:** Miconazole can significantly inhibit CYP3A4, increasing the plasma concentrations of numerous drugs metabolized by this enzyme. This can lead to serious adverse effects, including potentially fatal events. Concurrent use with certain medications like cisapride, astemizole, terfenadine, and oral midazolam is contraindicated. For other CYP3A4 substrates (e.g., some statins, anticoagulants like warfarin, immunosuppressants like cyclosporine/tacrolimus), caution and potential dose reduction of the interacting agent may be necessary.
* **Oral Contraceptives:** Some evidence suggests potential reduced efficacy of combined oral contraceptives due to decreased absorption, although this is generally considered less of a concern with vaginal preparations compared to oral antifungals. Advise patients to use backup contraception if concerns arise.
## Monitoring
* Monitor for signs and symptoms of vaginal candidiasis resolution.
* Assess for and manage any adverse effects.
* Be aware of potential drug interactions if the patient is taking other medications.
## Clinical Pearls
* Ensure complete insertion of the pessary for optimal efficacy.
* Treatment may be continued during menstruation, but efficacy may be affected. Advise patients to consult their healthcare provider.
* Sexual partners may require treatment if symptomatic.
* Avoid douching and tight-fitting synthetic clothing during treatment.
---
*Disclaimer: This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines for complete and up-to-date details before making any treatment decisions.*
